Javascript must be enabled to continue!
The use of venous jump grafts in pancreatic transplantation – no difference in patient or allograft outcomes – an update of the UNOS database
View through CrossRef
AbstractVenous jump grafts are used in pancreas transplantation to salvage a pancreas with a short portal vein or to facilitate an easier anastomosis. There have been no large studies evaluating the safety of venous jump grafts in pancreas transplantation. We analyzed theUNOSdatabase to determine whether venous jump grafts are associated with graft loss or patient death. Data fromUNOSon all adult pancreas transplant recipients 1996–2012 were analyzed. Venous extension grafts were used in 2657 cases; they were not in 18 124. Kaplan–Meier/product‐limit estimates analysis demonstrated similar patient survival (p < 0.641) and death‐censored graft survival (p < 0.351) at one, three, five,10, and 15 yr between subjects with and without venous jump grafts. There was a statistically significant difference in one‐yr unadjusted patient survival between the venous extension graft (94.9%) and the no‐venous extension graft (95.8%) groups (p < 0.045) and a borderline difference in one‐yr graft survival between the venous extension graft (84.1%) and the no‐venous extension graft (82.6%) groups (p < 0.055). There was no significant difference in patient survival or allograft survival at the three‐, five‐, 10‐, and 15‐yr intervals. The use of venous jump grafts is not associated with increased graft loss or mortality.
Title: The use of venous jump grafts in pancreatic transplantation – no difference in patient or allograft outcomes – an update of the UNOS database
Description:
AbstractVenous jump grafts are used in pancreas transplantation to salvage a pancreas with a short portal vein or to facilitate an easier anastomosis.
There have been no large studies evaluating the safety of venous jump grafts in pancreas transplantation.
We analyzed theUNOSdatabase to determine whether venous jump grafts are associated with graft loss or patient death.
Data fromUNOSon all adult pancreas transplant recipients 1996–2012 were analyzed.
Venous extension grafts were used in 2657 cases; they were not in 18 124.
Kaplan–Meier/product‐limit estimates analysis demonstrated similar patient survival (p < 0.
641) and death‐censored graft survival (p < 0.
351) at one, three, five,10, and 15 yr between subjects with and without venous jump grafts.
There was a statistically significant difference in one‐yr unadjusted patient survival between the venous extension graft (94.
9%) and the no‐venous extension graft (95.
8%) groups (p < 0.
045) and a borderline difference in one‐yr graft survival between the venous extension graft (84.
1%) and the no‐venous extension graft (82.
6%) groups (p < 0.
055).
There was no significant difference in patient survival or allograft survival at the three‐, five‐, 10‐, and 15‐yr intervals.
The use of venous jump grafts is not associated with increased graft loss or mortality.
Related Results
The validity and reliability of the “My Jump App” for measuring jump height of the elderly
The validity and reliability of the “My Jump App” for measuring jump height of the elderly
Background
The ability to jump has been related to muscle strength and power, speed and amplitude of the lower limbs movements, and specifically for the elderly, the vertical jump ...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Relative Net Vertical Impulse Determines Jumping Performance
Relative Net Vertical Impulse Determines Jumping Performance
The purpose of this investigation was to determine the relationship between relative net vertical impulse and jump height in a countermovement jump and static jump performed to var...
PB1673 FEASIBILITY AND OUTCOME OF ALLOGENEIC BONE MARROW TRANSPLANTATION IN ADULT PHI NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
PB1673 FEASIBILITY AND OUTCOME OF ALLOGENEIC BONE MARROW TRANSPLANTATION IN ADULT PHI NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Background:Acute lymphoblastic leukemia (ALL) is a rare disease in adults. Despite the novels therapies, clinical outcomes remain unsatisfactory. Bone marrow allograft still holds ...
Allograft nephrectomy vs. no‐allograft nephrectomy for renal transplantation: a meta‐analysis
Allograft nephrectomy vs. no‐allograft nephrectomy for renal transplantation: a meta‐analysis
AbstractObjectiveTo assess the safety and efficacy of allograft nephrectomy vs. no‐allograft nephrectomy for renal re‐transplantation.MethodsMedline (PubMed), Embase, Ovid, Cochran...
Vascular Grafts and Flow-through Flaps for Microsurgical Lower Extremity Reconstruction
Vascular Grafts and Flow-through Flaps for Microsurgical Lower Extremity Reconstruction
Background The use of vascular grafts is indicated in case of insufficient pedicle length or for complex defects involving both soft tissues and vessels. Venous grafts (for both ve...
Limitations of pediatric donor kidneys for transplantation
Limitations of pediatric donor kidneys for transplantation
BackgroundThe shortage of grafts for kidney transplantation (Tx) has resulted in an expansion of criteria for pediatric donors. However, the limitations of pediatric donors for kid...
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract
Pancreatic adenocarcinoma (PDAC) remains one of the most lethal cancers today and is expected to be the second cause of cancer death in the coming decade. M...

